Sign in to view content

Current United States Treatment Patterns for the Treatment of Proliferative Diabetic Retinopathy in the IRIS Registry

Jeremiah Brown, MD, MS, FASRS

Video
Published 2020

Related

How to Approach Proliferative Diabetic Retinopathy in 2020
Andrew A. Moshfeghi, MD, MBA, FASRS
Updates from the Field
2019
Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)
Dante Joseph Pieramici, MD
Annual Meeting Talks
2020
Diabetic Retinopathy Part I Take-Home Panel
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2019

Category: Diabetic Retinopathy

See more